All Stories

  1. Antigenic Drift of Hemagglutinin and Neuraminidase in seasonal H1N1 influenza Viruses from Saudi Arabia in 2014‐2015

    Article • Journal of Medical Virology, March 2020, Wiley

    Dr Karim El Bakkouri

  2. M2e-tetramer-specific memory CD4 T cells are broadly protective against influenza infection

    Article • Mucosal Immunology, March 2017, Nature

    Dr Karim El Bakkouri

  3. Hierarchical and Redundant Roles of Activating FcγRs in Protection against Influenza Disease by M2e-Specific IgG1 and IgG2a Antibodies

    Article • Journal of Virology, January 2017, ASM Journals

    Dr Karim El Bakkouri, Xavier Saelens

  4. Correction: Experimental Treatment with Favipiravir for Ebola Virus Disease (the JIKI Trial): A Historically Controlled, Single-Arm Proof-of-Concept Trial in Guinea

    Article • PLoS Medicine, April 2016, PLOS

    Dr Karim El Bakkouri

  5. Experimental Treatment with Favipiravir for Ebola Virus Disease (the JIKI Trial): A Historically Controlled, Single-Arm Proof-of-Concept Trial in Guinea

    Article • PLoS Medicine, March 2016, PLOS

    Dr Karim El Bakkouri

  6. Cutting Edge Approaches Toward Novel and Cross-Protective Influenza Vaccines

    Article • January 2012, Springer Science + Business Media

    Xavier Saelens, Dr Karim El Bakkouri

  7. The proton translocation domain of cellular vacuolar ATPase provides a target for the treatment of influenza A virus infections

    Article • British Journal of Pharmacology, August 2011, Wiley

    Dr Karim El Bakkouri

  8. A novel non-toxic combined CTA1-DD and ISCOMS adjuvant vector for effective mucosal immunization against influenza virus

    Article • Vaccine, May 2011, Elsevier

    Xavier Saelens, Dr Karim El Bakkouri

  9. Universal Vaccine Based on Ectodomain of Matrix Protein 2 of Influenza A: Fc Receptors and Alveolar Macrophages Mediate Protection

    Article • The Journal of Immunology, December 2010, The American Association of Immunologists

    Dr Karim El Bakkouri

  10. M2e-based universal influenza A vaccine

    Article • Vaccine, October 2009, Elsevier

    Xavier Saelens, Dr Karim El Bakkouri

  11. CTA1-M2e-DD: A novel mucosal adjuvant targeted influenza vaccine

    Article • Vaccine, February 2008, Elsevier

    Xavier Saelens, Dr Karim El Bakkouri

  12. LIND/ABIN-3 Is a Novel Lipopolysaccharide-inducible Inhibitor of NF- B Activation

    Article • Journal of Biological Chemistry, November 2006, American Society for Biochemistry & Molecular Biology (ASBMB)

    Dr Karim El Bakkouri

  13. Adenoviral gene transfer of ABIN‐1 protects mice from TNF/galactosamine‐induced acute liver failure and lethality†

    Article • Hepatology, August 2005, Wolters Kluwer Health

    Ben Wielockx, Dr Karim El Bakkouri

  14. 2′,5′-Oligoadenylate size is critical to protect RNase L against proteolytic cleavage in chronic fatigue syndrome

    Article • Experimental and Molecular Pathology, June 2005, Elsevier

    Dr Karim El Bakkouri

  15. Adenoviral Gene Transfer of the NF- B Inhibitory Protein ABIN-1 Decreases Allergic Airway Inflammation in a Murine Asthma Model

    Article • Journal of Biological Chemistry, February 2005, American Society for Biochemistry & Molecular Biology (ASBMB)

    Dr Karim El Bakkouri

  16. In vivoanti-tumour activity of recombinant MVM parvoviral vectors carrying the human interleukin-2 cDNA

    Article • The Journal of Gene Medicine, October 2004, Wiley

    Dr Karim El Bakkouri

  17. Ribonuclease L

    Article • February 2002, Taylor & Francis

    Dr Karim El Bakkouri

  18. Cloning and Sequencing of Defective Particles Derived from the Autonomous Parvovirus Minute Virus of Mice for the Construction of Vectors with Minimal cis-Acting Sequences

    Article • Journal of Virology, February 2001, ASM Journals

    Dr Karim El Bakkouri

  19. Helper-free generation of new oncotropic and oncotoxic vectors derived from MVM autonomous parvovirus

    Article • European Journal of Cancer, September 1999, Elsevier

    Dr Karim El Bakkouri

  20. Influence of Sequence and Size of DNA on Packaging Efficiency of Parvovirus MVM-Based Vectors

    Article • Human Gene Therapy, May 1999, Mary Ann Liebert Inc

    Dr Karim El Bakkouri